Joshua Jennings
Stock Analyst at TD Cowen
(3.59)
# 881
Out of 4,761 analysts
68
Total ratings
49.21%
Success rate
7.29%
Average return
Main Sectors:
Stocks Rated by Joshua Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AVR Anteris Technologies Global | Initiates: Buy | $15 | $8.25 | +81.82% | 1 | Jan 7, 2025 | |
| PODD Insulet | Maintains: Buy | $264 → $324 | $282.80 | +14.57% | 1 | Jan 3, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $100 → $110 | $104.49 | +5.27% | 7 | Dec 12, 2024 | |
| CBLL CeriBell | Maintains: Buy | $31 → $36 | $24.69 | +45.81% | 2 | Dec 9, 2024 | |
| TMDX TransMedics Group | Maintains: Buy | $175 → $120 | $71.95 | +66.78% | 9 | Nov 18, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $3.54 | +182.49% | 2 | Oct 18, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $50 | $3.55 | +1,308.45% | 1 | Oct 2, 2024 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $75 → $99 | $62.25 | +59.04% | 3 | Sep 16, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Hold | $143 → $119 | $104.83 | +13.52% | 1 | Sep 6, 2024 | |
| VCEL Vericel | Maintains: Buy | $55 → $60 | $52.00 | +15.38% | 2 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $83 → $80 | $76.65 | +4.37% | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $0.88 | +242.70% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $100 → $70 | $73.30 | -4.50% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $185 | $162.30 | +13.99% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 | $33.82 | +18.27% | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $365 → $400 | $382.78 | +4.50% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $60 | $33.43 | +79.48% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $34 | $31.00 | +9.68% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $18 | $7.48 | +140.64% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $114 → $125 | $88.78 | +40.80% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $25 | $17.68 | +41.40% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $130 | $134.92 | -3.65% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $5 | $2.20 | +127.27% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $117 | $89.94 | +30.09% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $450 | $14.38 | +3,029.35% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $12 | $10.61 | +13.10% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $306 → $275 | $227.43 | +20.92% | 1 | Feb 7, 2020 |
Anteris Technologies Global
Jan 7, 2025
Initiates: Buy
Price Target: $15
Current: $8.25
Upside: +81.82%
Insulet
Jan 3, 2025
Maintains: Buy
Price Target: $264 → $324
Current: $282.80
Upside: +14.57%
Boston Scientific
Dec 12, 2024
Maintains: Buy
Price Target: $100 → $110
Current: $104.49
Upside: +5.27%
CeriBell
Dec 9, 2024
Maintains: Buy
Price Target: $31 → $36
Current: $24.69
Upside: +45.81%
TransMedics Group
Nov 18, 2024
Maintains: Buy
Price Target: $175 → $120
Current: $71.95
Upside: +66.78%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $3.54
Upside: +182.49%
Allurion Technologies
Oct 2, 2024
Initiates: Buy
Price Target: $50
Current: $3.55
Upside: +1,308.45%
PROCEPT BioRobotics
Sep 16, 2024
Maintains: Buy
Price Target: $75 → $99
Current: $62.25
Upside: +59.04%
Zimmer Biomet Holdings
Sep 6, 2024
Maintains: Hold
Price Target: $143 → $119
Current: $104.83
Upside: +13.52%
Vericel
Aug 27, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $52.00
Upside: +15.38%
Aug 13, 2024
Maintains: Hold
Price Target: $83 → $80
Current: $76.65
Upside: +4.37%
Aug 8, 2024
Maintains: Buy
Price Target: $9 → $3
Current: $0.88
Upside: +242.70%
Jul 25, 2024
Downgrades: Hold
Price Target: $100 → $70
Current: $73.30
Upside: -4.50%
Jul 18, 2024
Maintains: Buy
Price Target: $195 → $185
Current: $162.30
Upside: +13.99%
May 10, 2024
Downgrades: Hold
Price Target: $40
Current: $33.82
Upside: +18.27%
Apr 11, 2024
Maintains: Buy
Price Target: $365 → $400
Current: $382.78
Upside: +4.50%
Mar 12, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $33.43
Upside: +79.48%
Aug 4, 2023
Maintains: Outperform
Price Target: $52 → $34
Current: $31.00
Upside: +9.68%
May 11, 2023
Maintains: Outperform
Price Target: $14 → $18
Current: $7.48
Upside: +140.64%
Feb 10, 2023
Maintains: Outperform
Price Target: $114 → $125
Current: $88.78
Upside: +40.80%
Dec 30, 2022
Maintains: Outperform
Price Target: $6 → $25
Current: $17.68
Upside: +41.40%
Dec 13, 2022
Maintains: Outperform
Price Target: $130
Current: $134.92
Upside: -3.65%
Nov 11, 2022
Maintains: Outperform
Price Target: $7 → $5
Current: $2.20
Upside: +127.27%
May 27, 2022
Maintains: Outperform
Price Target: $125 → $117
Current: $89.94
Upside: +30.09%
Dec 7, 2021
Initiates: Outperform
Price Target: $450
Current: $14.38
Upside: +3,029.35%
Sep 3, 2020
Initiates: Outperform
Price Target: $12
Current: $10.61
Upside: +13.10%
Feb 7, 2020
Downgrades: Market Perform
Price Target: $306 → $275
Current: $227.43
Upside: +20.92%